| 1 | [SID47199273] | Active | Potency | 0.4147 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | Potency | 0.4147 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID47199273] | Active | AC50 | 1.299 | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_Dose_CherryPick_Activity [AID504725, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | AC50 | 1.299 [uM] | | BioAssay | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_Dose_CherryPick_Activity | | AID | 504725 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 3 | [SID47199273] | Active | AC50 | 1.872 | C-LANA Counter Screen: DNA intercalators Measured in Biochemical System Using Plate Reader - 2117-02_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504727, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | AC50 | 1.872 [uM] | | BioAssay | C-LANA Counter Screen: DNA intercalators Measured in Biochemical System Using Plate Reader - 2117-02_Inhibitor_Dose_CherryPick_Activity_Set2 | | AID | 504727 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 4 | [SID47199273] | Active | Potency | 2.9093 | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | Potency | 2.9093 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 5 | [SID47199273] | Active | AC50 | 3.88 | Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme Measured in Biochemical System Using Plate Reader - 2105-02_Inhibitor_Dose_CherryPick_Activity [AID540359, Type: confirmatory] | glf gene product [Mycobacterium tuberculosis H37Rv] [gi:15610945] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | AC50 | 3.88 [uM] | | BioAssay | Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme Measured in Biochemical System Using Plate Reader - 2105-02_Inhibitor_Dose_CherryPick_Activity | | AID | 540359 | | BioAssay type | confirmatory | | Target | glf gene product [Mycobacterium tuberculosis H37Rv] [gi:15610945] | | PubMed | | | Data Table |  |
|
| 6 | [SID47199273] | Active | Potency | 4.1052 | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation [AID651600, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | Potency | 4.1052 [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation | | AID | 651600 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 7 | [SID47199273] | Active | Potency | 4.1052 | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation [AID651600, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | Potency | 4.1052 [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation | | AID | 651600 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 8 | [SID47199273] | Active | EC50 | 6.536 | Fluorescence Polarization Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of the LANA Histone H2A/H2B Interaction [AID435023, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:139472804] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | EC50 | 6.536 [uM] | | BioAssay | Fluorescence Polarization Cell-Free Homogeneous Dose Retest to Confirm Inhibitors of the LANA Histone H2A/H2B Interaction | | AID | 435023 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:139472804] | | PubMed | | | Data Table |  |
|
| 9 | [SID47199273] | Active | EC50 | 6.89 | Counterscreen for IDE activators: Fluorescence polarization-based biochemical high throughput dose response assay to identify fluorescent artifacts and/or optically active compounds [AID588442, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | EC50 | 6.89 [uM] | | BioAssay | Counterscreen for IDE activators: Fluorescence polarization-based biochemical high throughput dose response assay to identify fluorescent artifacts and/or optically active compounds | | AID | 588442 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID47199273] | Active | Potency | 7.0795 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID47199273] | Active | IC50 | 7.62 | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput counterscreen to identify inhibitors of TEM-1 metallo-beta-lactamase [AID2755, Type: confirmatory] | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | IC50 | 7.62 [uM] | | BioAssay | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput counterscreen to identify inhibitors of TEM-1 metallo-beta-lactamase | | AID | 2755 | | BioAssay type | confirmatory | | Target | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] | | PubMed | | | Data Table |  |
|
| 12 | [SID47199273] | Active | IC50 | 9.333 | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase [AID2754, Type: confirmatory] | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | IC50 | 9.333 [uM] | | BioAssay | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase | | AID | 2754 | | BioAssay type | confirmatory | | Target | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] | | PubMed | | | Data Table |  |
|
| 13 | [SID47199273] | Active | IC50 | 9.333 | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase [AID2754, Type: confirmatory] | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | IC50 | 9.333 [uM] | | BioAssay | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase | | AID | 2754 | | BioAssay type | confirmatory | | Target | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] | | PubMed | | | Data Table |  |
|
| 14 | [SID47199273] | Active | Potency | 12.9953 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | Potency | 12.9953 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 15 | [SID47199273] | Active | Potency | 12.9953 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | Potency | 12.9953 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 16 | [SID47199273] | Active | Potency | 12.9953 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | Potency | 12.9953 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 17 | [SID47199273] | Active | Potency | 12.9953 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | Potency | 12.9953 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 18 | [SID47199273] | Active | Potency | 16.3432 | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation in TR assay [AID651599, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | Potency | 16.3432 [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation in TR assay | | AID | 651599 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 19 | [SID47199273] | Active | Potency | 16.3432 | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation in TR assay [AID651599, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | Potency | 16.3432 [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation in TR assay | | AID | 651599 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 20 | [SID47199273] | Active | Potency | 31.6228 | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|
| 21 | [SID47199273] | Active | Potency | 35.4813 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 22 | [SID47199273] | Active | Potency | 50.1187 | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). [AID588795, Type: confirmatory] | flap endonuclease 1 [Homo sapiens] [gi:4758356] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). | | AID | 588795 | | BioAssay type | confirmatory | | Target | flap endonuclease 1 [Homo sapiens] [gi:4758356] | | PubMed | | | Data Table |  |
|
| 23 | [SID47199273] | Active | Potency | 70.7946 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | Potency | 70.7946 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 24 | [SID47199273] | Active | Potency | 70.7946 | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS [AID588453, Type: confirmatory] | thioredoxin reductase [Rattus norvegicus] [gi:8659577] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | Potency | 70.7946 [uM] | | BioAssay | qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS | | AID | 588453 | | BioAssay type | confirmatory | | Target | thioredoxin reductase [Rattus norvegicus] [gi:8659577] | | PubMed | | | Data Table |  |
|
| 25 | [SID47199273] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction. [AID2280, Type: screening] | defective in Germ Line Development family member (gld-1) [Caenorhabditis elegans] [gi:17507875] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction. | | AID | 2280 | | BioAssay type | screening | | Target | defective in Germ Line Development family member (gld-1) [Caenorhabditis elegans] [gi:17507875] | | PubMed | | | Data Table |  |
|
| 26 | [SID47199273] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon) [AID602123, Type: screening] | DNA-binding ATP-dependent protease La [Escherichia coli str. K-12 substr. MG1655] [gi:16128424] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon) | | AID | 602123 | | BioAssay type | screening | | Target | DNA-binding ATP-dependent protease La [Escherichia coli str. K-12 substr. MG1655] [gi:16128424] | | PubMed | | | Data Table |  |
|
| 27 | [SID47199273] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon) [AID602230, Type: screening] | DNA-binding ATP-dependent protease La [Escherichia coli str. K-12 substr. MG1655] [gi:16128424] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon) | | AID | 602230 | | BioAssay type | screening | | Target | DNA-binding ATP-dependent protease La [Escherichia coli str. K-12 substr. MG1655] [gi:16128424] | | PubMed | | | Data Table |  |
|
| 28 | [SID47199273] | Active | | | Fluorescence-based biochemical high throughput confirmation assay for activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) [AID504383, Type: screening] | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput confirmation assay for activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) | | AID | 504383 | | BioAssay type | screening | | Target | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] | | PubMed | | | Data Table |  |
|
| 29 | [SID47199273] | Active | | | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity [AID504423, Type: screening] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504423 | | BioAssay type | screening | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 30 | [SID47199273] | Active | | | Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6 [AID504406, Type: screening] | glf gene product [Mycobacterium tuberculosis H37Rv] [gi:15610945] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6 | | AID | 504406 | | BioAssay type | screening | | Target | glf gene product [Mycobacterium tuberculosis H37Rv] [gi:15610945] | | PubMed | | | Data Table |  |
|
| 31 | [SID47199273] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase [AID1527, Type: screening] | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase | | AID | 1527 | | BioAssay type | screening | | Target | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] | | PubMed | | | Data Table |  |
|
| 32 | [SID47199273] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase [AID1527, Type: screening] | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase | | AID | 1527 | | BioAssay type | screening | | Target | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] | | PubMed | | | Data Table |  |
|
| 33 | [SID47199273] | Active | | | Epi-absorbance-based counterscreen assay for common VIM-2 and IMP-1 inhibitors: biochemical high throughput screening assay to identify inhibitors of TEM-1 serine-beta-lactamase. [AID2184, Type: screening] | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Epi-absorbance-based counterscreen assay for common VIM-2 and IMP-1 inhibitors: biochemical high throughput screening assay to identify inhibitors of TEM-1 serine-beta-lactamase. | | AID | 2184 | | BioAssay type | screening | | Target | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] | | PubMed | | | Data Table |  |
|
| 34 | [SID47199273] | Active | | | Epi-absorbance-based confirmation biochemical high throughput screening assay to identify selective inhibitors of VIM-2 metallo-beta-lactamase. [AID1860, Type: screening] | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Epi-absorbance-based confirmation biochemical high throughput screening assay to identify selective inhibitors of VIM-2 metallo-beta-lactamase. | | AID | 1860 | | BioAssay type | screening | | Target | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] | | PubMed | | | Data Table |  |
|
| 35 | [SID47199273] | Active | | | Counterscreen for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and receptor-interacting serine-threonine kinase 2 (RIPK2): Fluorescence-based cell-based high throughput assay to identify non-selective inhibitors of the beta-lactamase enzyme (BLA) [AID624371, Type: screening] | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and receptor-interacting serine-threonine kinase 2 (RIPK2): Fluorescence-based cell-based high throughput assay to identify non-selective inhibitors of the beta-lactamase enzyme (BLA) | | AID | 624371 | | BioAssay type | screening | | Target | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] | | PubMed | | | Data Table |  |
|
| 36 | [SID47199273] | Active | | | Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction [AID2629, Type: screening] | LANA [Human herpesvirus 8] [gi:139472804] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction | | AID | 2629 | | BioAssay type | screening | | Target | LANA [Human herpesvirus 8] [gi:139472804] | | PubMed | | | Data Table |  |
|
| 37 | [SID47199273] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) [AID493008, Type: screening] | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF) | | AID | 493008 | | BioAssay type | screening | | Target | cardiac alpha tropomyosin [Sus scrofa] [gi:1927] | | PubMed | | | Data Table |  |
|
| 38 | [SID47199273] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 39 | [SID47199273] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 40 | [SID47199273] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 41 | [SID47199273] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) [AID624037, Type: screening] | CHRM5 gene product [Homo sapiens] [gi:7108336] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5) | | AID | 624037 | | BioAssay type | screening | | Target | CHRM5 gene product [Homo sapiens] [gi:7108336] | | PubMed | | | Data Table |  |
|
| 42 | [SID47199273] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 43 | [SID47199273] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 44 | [SID47199273] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 45 | [SID47199273] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 46 | [SID47199273] | Active | | | Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE) [AID493087, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE) | | AID | 493087 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 47 | [SID47199273] | Active | | | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) [AID2797, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) | | AID | 2797 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 48 | [SID47199273] | Active | | | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) [AID2797, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) | | AID | 2797 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 49 | [SID47199273] | Active | | | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) [AID2797, Type: screening] | vasopressin V1a receptor [Homo sapiens] [gi:4502331] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R) | | AID | 2797 | | BioAssay type | screening | | Target | vasopressin V1a receptor [Homo sapiens] [gi:4502331] | | PubMed | | | Data Table |  |
|
| 50 | [SID47199273] | Active | | | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). [AID2129, Type: screening] | bcl-xL [Homo sapiens] [gi:510901] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 47199273 | | CID | 23723895 | | Outcome | Active | | BioAssay | Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL). | | AID | 2129 | | BioAssay type | screening | | Target | bcl-xL [Homo sapiens] [gi:510901] | | PubMed | | | Data Table |  |
|